Obesity & Cancer
The overall purpose of the Obesity and Cancer Section is to promote research, education and advocacy related to cancer, including: understanding how obesity affects etiology, prevention and management of cancer; the development of effective strategies, interventions and educational efforts that may reduce the impact of obesity on cancer risk and progression; and promote the dissemination of knowledge of the obesity-cancer relationship to the scientific community, clinicians and the public.
Goals
Research
- Facilitate networking among Section members and others to promote more research in obesity and cancer, across the continuum of research from cell and molecular biology, integrative biology, clinical studies, and population studies.
- Encourage members (and recruit new members) to submit abstracts relevant to obesity and cancer to The Obesity Society's Annual Scientific Meeting.
- Promote participation in TOS and cancer-obesity research among junior investigators and early career scientists.
Education
- Develop symposia concepts focused on obesity and cancer for The Obesity Society's Annual Scientific Meeting.
- Contribute to the Society's target clinicians, including participation in meeting clinician-professional practice sessions, to increase their awareness of the relationship between obesity and cancer risk and progression.
- Participate in the development and promote the dissemination of the American Cancer Society diet and physical activity prevention recommendations (To be updated in 2011)
Advocacy
- Communicate accurate information about the obesity-cancer relationship to professional and lay audiences, as a representative of the Society and the Section.
- Encourage the involvement of cancer researchers and advocates in obesity research and education, through membership in the Society and participation in Society activities.
News
Join the Obesity and Cancer Section
All section members must be a member of The Obesity Society.
If you are not a member of The Obesity Society, join today. Be certain to select the Obesity and Cancer Section when completing your profile.
If you are already a member and would like to join the Obesity and Cancer Section please login to your member profile and select the Obesity and Cancer Section. Once you have updated your profile, you will receive all communications pertaining to the section.
Please contact Sadie Campbell, This e-mail address is being protected from spambots. You need JavaScript enabled to view it , Governance and Executive Assistant if you have any questions.
Obesity & Cancer ListServ
Section Listservs are now available for TOS members! Listservs are a great place to find and to share knowledge and ideas. Sign up Today!
Member Listserv Rules & Etiquette
Leaders
Christos Mantzoros, MD, FTOS (Chair 2012–2013)
Harvard Medical School, Boston, MA
Christos Mantzoros is Professor of Medicine at Harvard Medical School. He serves as the Chief of Endocrinology, Diabetes and Metabolism at the Boston VA Healthcare System and the Director of the Human Nutrition Unit of the Division of Endocrinology Diabetes and Metabolism at Beth Israel Deaconess Medical Center. Dr. Mantzoros obtained an MD and DSc from the University of Athens Medical School, a Master's in Clinical Epidemiology from Harvard School of Public Health and a Master’s in Medical Sciences (Clinical Investigation) from Harvard Medical School. He has received Board certification in Internal Medicine, Endocrinology, Diabetes and Metabolism and in Clinical Nutrition. Dr. Mantzoros sees patients, teaches and conducts research on obesity and diabetes / metabolic diseases. He has published as an Editor two books (one on “Diabetes and Obesity” and one on “Nutrition and Metabolism” with more than two editions each), his research has resulted in more than 340 publications in Medline, more than 65 publications under the collaborative Look Ahead Research Group, more than 120 chapters and reviews and has received more than 16,650 citations with a Hirsch Index H=68. He is the Editor-in-Chief of the journal Metabolism and is a member of ASCI. He has been given several awards including the American Association of Clinical Endocrinology Frontiers in Science Award, the Novartis Award in Diabetes and Metabolic Diseases, the Lilly Award by the North American Association for the Study of Obesity, the American Society for Nutrition Mead Johnson Award, the HypoCCS award in Paris, France, the Wilhelm Friedrich Bessel Award by the Humboldt Foundation of Germany, The Hygeia Award of the New England Hellenic Medical and Dental Society, the Outstanding Investigator Award by the American Federation of Medical Research, the Berson Award by the American Physiological Society (FASEB) and the BIDMC, Harvard Medical School, award for excellence in Mentoring.
Zora Djuric PhD (Past Chair)
University of Michigan, Ann Arbor, MI
Zora Djuric, Ph.D., is a Research Professor in the Departments of Family Medicine and Environmental Health Sciences (Nutrition Program) at the University of Michigan. She is also a member of the University of Michigan Comprehensive Cancer Center. Dr. Djuric has been studying the role of dietary patterns on cancer risk reduction using biomarker endpoints for some time, focusing mainly on clinical intervention studies. These studies have typically included individuals at increased cancer risk. Her current focus is on colon cancer prevention using a Mediterranean exchange list diet. Dr. Djuric recently completed service on the Chemo and Dietary Prevention Study section for NIH. She became a Fellow Member of the TOS in 2005.
